复星医药(02196.HK)拟10月28日举行董事会会议审批季度业绩

Core Viewpoint - Fosun Pharma (02196.HK) announced that its board of directors will hold a meeting on October 28, 2025, to consider and approve the third-quarter results for the nine months ending September 30, 2025, and to publish these results [1] Summary by Category - Company Announcement - The board meeting is scheduled for October 28, 2025 [1] - The meeting will focus on the financial performance of the company and its subsidiaries for the third quarter [1] - Results will cover the period ending September 30, 2025 [1]